SSATFSmall State Agency Task Force (Texas)
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
Brought forth by similar concerns and increasing negative attention, the National Lipid Association established a Statin Safety Assessment Task Force (SSATF) charged with evaluating the effects and safety of statin therapy.
Given this variability, the SSATF conducted a review of twenty-one independent clinical trials, concluding that while muscular symptoms are the most prevalent side-effect of statin use they are rare.48 The Task Force concluded that up to 3% of patients taking statins will experience myalgia and five patients per 100,000 person years will experience myositis.